Clinical Trial 51382

Oxnard, CA 93030


Summary:

Epstein-Barr virus (EBV) is a viral infection that spreads through saliva and body fluids. EBV in adolescents and young adults can lead to infectious mononucleosis. People with mononucleosis (mono) experience extreme fatigue, fever and body aches. Once you get EBV, the infection stays within your body in a dormant state where it's inactive or sleeping. The virus can be reactivated and produce symptoms again, regardless of when you first acquired the virus. Over 90% of mono cases are caused by the Epstein-Barr virus. Most cases of Epstein-Barr virus affect: Children, Teenagers, Young adults But anyone can get the virus. We currently have no vaccine to prevent this virus that affects the younger population. There are over 3 million cases of EBV reported yearly in the US.



Criteria:

1. Must be between the age of 18 and 30 and in good general health.

2. Female participants must be either not of child bearing potential or practicing adequate contraception (condoms are an acceptable form of contraception).

Exclusions:

Person has NOT had significant exposure to someone with severe acute respiratory syndrome coronavirus 2 or COVID-19 in the past 14 days.

Person has NO medical, psychiatric, or occupational condition that may pose an additional risk as a result of participation.

Person has NO history of myocarditis and/or pericarditis.


Qualified Participants May Receive:

The compensation for participating in this study is $2,600.00 USD


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.